Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...
A new Crispr-powered optical blood test detects lung cancer biomarkers at sub-attomolar levels, offering earlier molecular detection than conventional PCR or imaging.
Private companies are capitalizing on this quest for information. Grail’s Galleri blood test screens for more than 50 ...
Scientists in China say they've built a simple blood test that can spot tell‑tale warning signs of cancer far earlier than a tumour would ever show up on a hospital scanner. The light-based sensor, ...
Blood tests are helpful for monitoring your overall health. But research suggests they can also give us clues about the ...
PALO ALTO, Calif., Dec. 5, 2025 /PRNewswire/ -- DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, announced ...
Discover how precision lung cancer care tackles gene fusions, new HER2/ROS1/ALK drugs, expanded screening, and liquid biopsies shaping 2026 treatment.
A new light-based sensor detects cancer markers at near-zero concentrations.
February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and survivorship lung health.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results